Form 4 for ABCL AbCellera Biologics Inc.
Accepted 2023-09-14 00:00:00 ET · period of report 2023-09-12 · accession 0001703057-23-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-14 | 2023-09-12 | ABCL | Lecault Veronique | COO, Dir | P - Purchase | $5.19 | +20.0K | 2.04M | +1.0% | +$103.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-09-12 | P | A | 20,000 | $5.19 | 2,040,122 | D | — | — |